{"id":1593,"date":"2025-04-07T13:10:00","date_gmt":"2025-04-07T13:10:00","guid":{"rendered":"https:\/\/dislogroup.com\/?p=1593"},"modified":"2025-10-27T08:19:24","modified_gmt":"2025-10-27T08:19:24","slug":"dislog-group-renforce-son-pole-sante-avec-lentree-au-capital-de-afrobiomedic","status":"publish","type":"post","link":"https:\/\/dislogroup.com\/en\/dislog-group-renforce-son-pole-sante-avec-lentree-au-capital-de-afrobiomedic\/","title":{"rendered":"Dislog Group strengthens its healthcare division by acquiring a stake in Afrobiomedic"},"content":{"rendered":"<p>As part of its development strategy in the healthcare sector, Dislog Group announces the signature of a memorandum of understanding for the acquisition of 70% of the capital of Afrobiomedic, a leading player in specialized cardiology medical devices.<br>This operation is in line with our ambition to structure a national champion for medical devices and actively contribute to improving the healthcare sector in Morocco, by making cutting-edge medical technologies more accessible. Afrobiomedic brings recognized expertise in interventional and structural cardiology, rhythmology and vascular neuroradiology.<br>Afrobiomedic joins our healthcare division, alongside Megaflex, Kosmopharm, Steripharma, SomaPharma, Africare and Dislog Sant\u00e9, as part of an industrial integration strategy covering the entire value chain.<br><br>\"We believe in the potential for industrial, human and operational synergies around a common project focused on innovation and impact,\" emphasizes the CEO. <a href=\"https:\/\/www.linkedin.com\/in\/ACoAAAe1otwB4_qRtjY4N1tOBvpQjPn19M7fCUw\"><\/a>Moncef Belkhayat, President of Dislog Group.<br><br>Special thanks to <a href=\"https:\/\/www.linkedin.com\/in\/ACoAAAzlUlQBQOR90BVTKNI-UKGsN93DOSBfxW0\"><\/a>Driss NASR, founder and sole shareholder of Afrobiomedic, who retains 30% of the capital and will continue to manage the company to support its growth.<\/p>","protected":false},"excerpt":{"rendered":"<p>As part of its development strategy in the healthcare sector, Dislog Group announces the signature of a memorandum of understanding for the acquisition of 70% of the capital of Afrobiomedic, a leading player in specialized cardiology medical devices, in line with our ambition to structure a national champion in medical devices and [...].<\/p>","protected":false},"author":3,"featured_media":1595,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-1593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsroom"],"_links":{"self":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/comments?post=1593"}],"version-history":[{"count":1,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1593\/revisions"}],"predecessor-version":[{"id":1596,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1593\/revisions\/1596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/media\/1595"}],"wp:attachment":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/media?parent=1593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/categories?post=1593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/tags?post=1593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}